Related Experiment Video
Updated: Aug 9, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Autoimmune pathogenesis and autoimmune hemolytic anemia
1Department of Laboratory Medicine, St. Micheal's Hospital, University of Toronto, Ontario, Canada. semplej@smh.toronto.on.ca
Abstract:
Autoimmune hemolytic anemia (AIHA) is an autoimmune disorder in which autoantibodies are directed against an individual's own red blood cells (RBCs), leading to enhanced clearance through Fc receptor (FcR)-mediated phagocytosis. Although there is a large literature relating to clinical aspects of AIHA, relatively little work addresses how IgG autoantibodies are actually produced against RBC autoantigens. This review will first discuss the current understanding of autoimmunity in general and then focus on the knowledge of the immunopathogenic mechanisms responsible for autoantibody production in AIHA. Both human and animal studies will be discussed. Understanding theses mechanism is vital for developing antigen-specific immunotherapies to treat the disease.
Related Concept Videos
What is the Immune System?
Regulation of Hematopoietic Stem Cells
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Hypersensitivity Reactions: Cytolytic Reactions
Type I Diabetes I: Introduction
Type I Diabetes II: Pathophysiology

